SECFilings.com helps investors track public company disclosures with smart tools and real-time alerts. Trusted by thousands of investors daily.
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.
Form 8-K - Current report - Item 2.02 Item 9.01
Form 8-K - Current report - Item 8.01
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Form 8-K - Current report - Item 5.02
Form 8-K - Current report - Item 2.02 Item 9.01
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Form 8-K - Current report - Item 2.02 Item 9.01
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Form 8-K - Current report - Item 2.02 Item 9.01
Form 8-K - Current report - Item 8.01 Item 9.01
Form 11-K - Annual report of employee stock purchase, savings and similar plans
Form 8-K - Current report - Item 5.07
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Form 8-K - Current report - Item 2.02 Item 9.01
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Form 8-K - Current report - Item 2.02 Item 9.01
Form 8-K - Current report - Item 1.01 Item 8.01 Item 9.01
Form S-8 - Securities to be offered to employees in employee benefit plans
Form 8-K - Current report - Item 5.04 Item 9.01
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Form 8-K - Current report - Item 2.02 Item 9.01
Form 8-K - Current report - Item 8.01 Item 9.01
Form 8-K/A - Current report: [Amend] - Item 5.02
Form 8-K - Current report - Item 1.01 Item 8.01 Item 9.01
Form 8-K - Current report - Item 7.01
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Form 8-K - Current report - Item 2.02 Item 9.01
Form 8-K - Current report - Item 5.02
Form 11-K - Annual report of employee stock purchase, savings and similar plans
Form 8-K - Current report - Item 5.02 Item 5.07 Item 9.01
Form S-8 - Securities to be offered to employees in employee benefit plans
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Form 8-K - Current report - Item 2.02 Item 9.01
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Form 8-K - Current report - Item 2.02 Item 9.01
Form 8-A12B - Registration of securities [Section 12(b)]
Form 8-K - Current report - Item 1.01 Item 8.01 Item 9.01
Form 8-K - Current report - Item 5.02 Item 9.01
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Form 8-K - Current report - Item 2.02 Item 9.01
Form 8-K - Current report - Item 1.01 Item 8.01 Item 9.01
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Form 8-K - Current report - Item 2.02 Item 9.01
Form 11-K - Annual report of employee stock purchase, savings and similar plans
Form 8-K - Current report - Item 5.07
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Form 8-K - Current report - Item 2.02 Item 9.01
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Form 8-K - Current report - Item 5.02 Item 9.01
Form 8-K - Current report - Item 2.02 Item 9.01